Methodological considerations in evaluating antianxiety drugs.
D001007:Anxiety / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D006801:Humans; D007406:Interview, Psychological; D008722:Methods; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*
D010919:Placebos; D014149:Tranquilizing Agents